CompareSkinVisionvsLegit.Health

SkinVision is a consumer-facing AI dermatology app for consumers, using smartphone photos to assess lesion risk and guide next steps.

1. Clinical role: It supports lesion risk assessment and monitoring rather than autonomous dermatology, so in-person evaluation remains essential for suspicious or changing skin findings.
2. Best-fit environment: Consumers may find it most useful for tracking lesions between visits when image capture and professional follow-up remain available.
3. Implementation checks: Buyers should confirm intended-use scope, image capture standards, market-specific regulatory framing, and clinician oversight before use across patient-facing or clinical settings.
4. Access model: A free tier is available, with paid plans expanding access depending on the user or program.

SkinVision is best evaluated as a consumer monitoring tool whose value depends on image quality, appropriate escalation, and dermatology follow-up.

Legit.Health is a clinical-grade dermatology AI platform for dermatology and primary care teams, supporting lesion assessment, severity scoring, and longitudinal tracking.

1. Clinical role: It supports lesion triage and monitoring rather than autonomous dermatology, so in-person assessment remains essential for suspicious or changing skin findings.
2. Best-fit environment: Dermatology and primary care teams fit best where image capture, review, and follow-up pathways are established.
3. Implementation checks: Buyers should confirm intended-use scope, image-capture standards, market-specific regulatory framing, and clinician oversight before deployment in patient-facing or clinical settings.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than publicly posted, making deployment scope an important consideration.

Legit.Health is best evaluated as a lesion-assessment and tracking layer whose fit depends on clinical oversight and regional regulatory scope.